Affymax News
Most Popular Affymax Story
Affymax readies blockbuster alternative to Epogen
Affymax hopes to get an FDA approval for its experimental anemia treatment Hematide next year, and that could leave the developer perfectly positioned to take advantage of new Medicare rules capping Read more...
Latest Headlines
- November 18, 2011
- August 11, 2011
- February 16, 2010
- February 17, 2009
- August 29, 2008
- February 1, 2007
- February 1, 2007
- December 14, 2006
- August 2, 2006
- July 30, 2006
- July 5, 2006
- June 26, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
